Search
El Paso, TX Paid Clinical Trials
A listing of 150 clinical trials in El Paso, TX actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
145 - 150 of 150
There are currently 150 clinical trials in El Paso, Texas looking for participants to engage in research studies. Trials are conducted at various facilities, including El Paso Children's Hospital, Texas Tech University Health Sciences Center, GSK Investigational Site and Texas Tech University Health Sciences Center El Paso. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Featured Trial
Major Depressive Disorder Clinical Study
Recruiting
Is depression weighing you down? Local major depressive disorder clinical studies are now enrolling participants in the area. Participating in research studies helps contribute to the advancement of future medicine and treatment options. There is no obligation to take part and health insurance is not required.
Conditions:
Major Depressive Disorder
Major Depression
Major Depressive Episode
Major Depressive Disorder (MDD)
Major Depressive Disorders
Featured Trial
Hyperacusis Activities Treatment-Online Study
Recruiting
Are you experiencing hyperacusis? If so, we are recruiting adults with hyperacusis to complete a clinical trial supported by the National Institutes of Health. The study involves participating in a remote counseling program and sound therapy trial for hyperacusis, Hyperacusis Activities Treatment-Online.
Conditions:
Hyperacusis
Tinnitus
Hearing Loss
Featured Trial
Child/Teen Migraine Study
Recruiting
Become part of a clinical trial today and play a role in driving medical research forward, aiding in the discovery of groundbreaking therapies. Get rewarded for your time with monetary compensation and enjoy access to medical treatment at no charge.
Surveillance AFter Extremity Tumor surgerY
Recruiting
Following treatment for a primary extremity sarcoma, patients remain at risk for the development of local and systemic disease recurrence. Metastasis (distant recurrence) to the lung is the most frequent single location of disease recurrence in sarcoma patients, occurring in almost half of all patients. Therefore, careful post-operative surveillance is an integral element of patient care. However, the detection of metastases does not necessarily affect long-term survival and may negatively impac... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
10/04/2022
Locations: Texas Tech Health Sciences Center, El Paso, Texas
Conditions: Soft Tissue Sarcoma, Lung Metastases
Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer
Recruiting
This is a Phase 3, open-label, randomized, clinical trial evaluating the efficacy and safety of gedatolisib plus fulvestrant with or without palbociclib for the treatment of patients with locally advanced or metastatic HR+/HER2- breast cancer following progression on or after CDK4/6 and aromatase inhibitor therapy.
Condition or disease:
Breast Cancer
Intervention/treatment:
Drug: Gedatolisib
Drug: Palbociclib
Drug: Fulvestrant
Drug: Alpelisib
Phase 3
Gender:
All
Ages:
18 years and above
Trial Updated:
08/02/2022
Locations: William Beaumont Army Medical Center, El Paso, Texas
Conditions: Breast Cancer
Safety, Tolerability, PK, and Analgesic Effect of INL-001 in Children Following Open Inguinal Hernia Repair
Recruiting
A multicenter, single-dose study in children 12 to <17 years of age, 6 to <12 years of age, and 2 to <6 years of age who are scheduled for elective open inguinal hernia repair. Enrollment in this study will start with the oldest age group (12 to <17 years) and will continue in a stepwise fashion until appropriate doses are established for all 3 pediatric age groups (12 to <17 years, 6 to <12 years, 2 to <6 years).
Gender:
All
Ages:
Between 2 years and 16 years
Trial Updated:
07/23/2021
Locations: El Paso Children's Hospital, El Paso, Texas
Conditions: Inguinal Hernia, Postoperative Pain
Retention of Whole-body Training Effects on Ambulatory Function in Children With Cerebral Palsy
Recruiting
This study will evaluate the retention effects of a four-week whole-body vibration training intervention in children with Cerebral Palsy. The primary outcomes for this study are gait function, including Timed Up and Go and the two-minute walk test. Secondary outcomes of this study include lower extremity gait function, coordination, and gait variability. For this study, a total of 10 children with Cerebral Palsy (CP) will be recruited with 5 being randomly placed into an experimental group and 5... Read More
Gender:
All
Ages:
Between 8 years and 12 years
Trial Updated:
07/02/2021
Locations: The University of Texas at El Paso, El Paso, Texas
Conditions: CP, Gait Disorders, Neurologic, Locomotion Disorder, Neurologic
Molecular Profiling After Neoadjuvant Chemotherapy for Triple-negative Breast Cancer
Recruiting
Neoadjuvant chemotherapy (NACT) can induce complete pathologic response (pCR) in approximately 35-55% of patient with triple-negative breast cancer (TNBC). These patients have excellent long term survivals. On the other hand patients with residual disease exhibit a high rate of local or metastatic. Although it has been successful in some regards, randomized trials have shown similar rates of mortality between patients receiving NACT and adjuvant chemotherapy (ACT). The goal of this study is to u... Read More
Gender:
Female
Ages:
Between 18 years and 86 years
Trial Updated:
04/22/2020
Locations: Texas Tech University Health Sciences Center- El Paso, El Paso, Texas
Conditions: Triple-negative Breast Cancer
Use of the OMNIĀ® Surgical System in Combination With Cataract Extraction in Open Angle Glaucoma
Recruiting
This study will prospectively assess the clinical effect of ab-interno transluminal viscoelastic delivery and trabeculotomy performed using the OMNI Surgical System in combination with Cataract Extraction on intraocular pressure (IOP) and the use of IOP-lowering medications in patients with mild-moderate open angle glaucoma (OAG).
Gender:
All
Ages:
22 years and above
Trial Updated:
02/28/2019
Locations: El Paso Eye Surgeons, El Paso, Texas
Conditions: Open Angle Glaucoma
145 - 150 of 150